HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A rapid method to study the relationship between IDDM and HLA-DQ beta 57 Asp.

Abstract
We have developed a rapid and simple method to detect the relation between HLA-DQ beta 57 Asp and Chinese IDDM patients. The method involved the selective amplification of a DNA fragment from the HLA-DQ B1 gene by using the mutagenic primers. After PCR, if the HLA-DQ beta 57 was Asp, then there was an artificially created restriction enzyme cutting site. We then can accurately obtain the results by enzyme digestion and electrophoresis. Sixty-nine IDDM patients and 30 nondiabetic control subjects were analyzed using this method. Twenty-two (42%) IDDM patients had non-Asp 57 homozygous, 31/45%) were Asp/non-Asp 57 heterozygous, and 9 (13%) had Asp-57 homozygous. Of the 30 control subjects, the number of cases for these three types were 6 (20%), 18 (60%), and 6 (20%), respectively. The relative risk of homozygous DQ beta 57 non-Asp in our group was 2.9 and the p value was greater than 0.05. Using this kind of approach, we were able to provide a simple, rapid, and non-radioactive method to detect whether the HLA DQ beta 57 was Asp or not.
AuthorsY W Huang, L S Lee, M C Shih, Y H Pai, Y J Lee, J G Chang
JournalTissue antigens (Tissue Antigens) Vol. 44 Issue 3 Pg. 155-8 (Sep 1994) ISSN: 0001-2815 [Print] England
PMID7839347 (Publication Type: Journal Article)
Chemical References
  • Genetic Markers
  • HLA-DQ Antigens
  • HLA-DQ beta-Chains
  • HLA-DQbeta antigen
  • DNA Restriction Enzymes
Topics
  • Adolescent
  • Aged
  • Base Sequence
  • Child
  • DNA Restriction Enzymes
  • Diabetes Mellitus, Type 1 (genetics)
  • Female
  • Genetic Markers
  • HLA-DQ Antigens (genetics)
  • HLA-DQ beta-Chains
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Polymerase Chain Reaction (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: